Medical Oncologist
Treatment options
Choosing surgery with a BRCA or other high-risk mutation
If you have breast cancer and carry a high-risk gene change, surgery choice involves treating the current cancer and managing a higher chance of new cancers later. This page explains the options from lumpectomy to bilateral mastectomy, how gene results fit timing, how genes differ, and care beyond the breast.
MM
Medically reviewed by Dr. Muralidhar MuddusettyConsultant Surgical Oncologist · MBBS (AIIMS), MS (Surgery, AIIMS), DNB (Surgical Oncology), MRCS (Edinburgh) · last reviewed September 2026, next review due September 2027
17+specialists on panel
15,000+patients treated
35+centres across Telangana & AP
4.8★ / 800+Google rating
On this page
- How do you choose breast cancer surgery if you carry a BRCA or other high-risk mutation?
- Surgical options for gene carriers with breast cancer
- How the options compare for carriers
- The vocabulary, in plain language
- Honest realities for gene carriers
- Getting gene results in time to help
- Other parts of care for carriers
- What people assume about surgery for BRCA carriers
- Common questions about surgery choice with a BRCA mutation
The short answer
How do you choose breast cancer surgery if you carry a BRCA or other high-risk mutation?
If you have breast cancer and carry a harmful change in BRCA1, BRCA2 or another high-risk gene such as PALB2, your surgery choice involves two questions rather than one. The first is how to treat the cancer you have. For many carriers, lumpectomy followed by radiotherapy treats the current cancer as effectively as mastectomy, and studies generally show similar survival. The second question is how to manage the higher chance of a new, separate cancer developing later, in either the treated breast or the other breast. This is where carriers differ from other women. Because the lifetime chance of a new breast cancer is considerably higher, many carriers consider removing both breasts, called bilateral mastectomy, at the time of treatment or later. Others choose lumpectomy or single mastectomy and then intensive screening with yearly MRI and mammograms. Your age matters, as younger women have more years of risk ahead. The gene matters too. TP53 carriers usually avoid radiotherapy where possible, so mastectomy is often favoured. Knowing your gene result before surgery is helpful, and rapid genetic testing can often be arranged for newly diagnosed women who meet testing criteria. Ovarian cancer risk also needs a plan. The decision does not need to be rushed, because treating the first cancer well matters most, and extra surgery can be done later.
Lumpectomy can still be safe
For many carriers, lumpectomy with radiotherapy treats the current cancer effectively.
New cancer risk is the key difference
Carriers have a higher chance of a second breast cancer over time.
Gene results help before surgery
Knowing your result allows a single, well-planned decision.
This page gives general information only. Your breast and genetics teams will help you weigh the options.Your options
Surgical options for gene carriers with breast cancer
All of these are recognised choices. The right one depends on your cancer, age and priorities.
Lumpectomy with radiotherapy
Treats the current cancer and keeps the breast, followed by close screening of both breasts.
Single mastectomy
Removes the affected breast; the other breast is screened closely or removed later if you wish.
Radiotherapy may still be needed for some cancers.Bilateral mastectomy
Removes both breasts, treating the cancer and lowering the chance of a new cancer on the other side.
Staged approach
Treat the current cancer first, and decide on the other breast later.
Useful when
- Gene results are still awaited
- Chemotherapy must start soon
- You need more time to decide
At a glance
How the options compare for carriers
Question
General picture
Treatment of the current cancer
Lumpectomy with radiotherapy and mastectomy are both effective for suitable cancers
New cancer in the treated breast
More likely over time after lumpectomy than after mastectomy
New cancer in the other breast
Greatly lowered only if the other breast is removed
Surgery and recovery
Smallest with lumpectomy; largest with bilateral mastectomy and reconstruction
Ongoing breast screening
Needed for any breast that remains; usually not after both are removed
Not sure whether this applies to you?
Ask an oncologistWords you may hear
The vocabulary, in plain language
- Germline mutation
- A gene change present in every cell from birth, which can be passed to children.
- Rapid genetic testing
- Testing arranged quickly after diagnosis so results can guide surgery.
- Bilateral mastectomy
- Removal of both breasts.
- Contralateral breast cancer
- A new cancer in the other breast.
- Ipsilateral new primary
- A new, separate cancer in the same breast that was treated before.
- Risk-reducing salpingo-oophorectomy
- Removal of the ovaries and fallopian tubes to lower ovarian cancer risk.
Talk to our team
Have a question about your situation?
Call the helpline or leave your details, and someone will help you arrange a consultation at the CION centre nearest you. One helpline serves every CION centre.
Call 1800 202 8726
Helpline open 24/7
Being straight with you
Honest realities for gene carriers
This is a heavy decision at a hard time, and it is fair to take it step by step.
More surgery does not always mean longer life
Survival depends first on the current cancer, and extra surgery mainly lowers the chance of new cancers.
Genes differ
BRCA1, BRCA2, PALB2 and TP53 carry different risks, and moderate-risk genes are handled differently.
Gene results can take time
Waiting for results may be worthwhile, but it should not delay urgent cancer treatment.
Bilateral surgery has more complications
Two-sided operations, especially with reconstruction, carry more risk of wound problems and further surgery.
What this page cannot tell you
It cannot choose between the options for you. Your breast, genetics and oncology teams can guide you together.
Timing
Getting gene results in time to help
If you meet criteria for genetic testing, asking early can make the surgery decision simpler.
Who is often tested at diagnosis
Women diagnosed young, those with triple-negative cancer, strong family history, or cancers in both breasts are commonly offered testing.
Ask about rapid testing
Some laboratories can return results within a few weeks, which may fit before surgery.
Chemotherapy first can give time
If chemotherapy is planned before surgery, results usually arrive before the operation.
If results come after surgery
You can still decide on further surgery later, once treatment is complete.
Beyond the breast
Other parts of care for carriers
A high-risk gene affects more than the breast, and a complete plan looks at the wider picture.
Ovarian cancer risk
BRCA carriers are usually advised to consider removing the ovaries and tubes at an age guided by the gene.
Medicines linked to your gene
Some targeted medicines work particularly well for BRCA-related cancers, and your oncologist will advise whether they apply.
Family members
Relatives can be offered testing, helping them plan screening or prevention.
Other cancers
Depending on the gene, pancreatic, prostate or skin checks may be discussed for you or relatives.
Commonly believed
What people assume about surgery for BRCA carriers
BRCA carriers cannot have a lumpectomy.
Many carriers can have lumpectomy safely, with similar survival for the current cancer.
Double mastectomy always improves survival for carriers.
It lowers new cancer risk; any survival gain depends on age, gene and the first cancer.
The decision must be made before the first operation.
Further surgery can be planned later if needed.
All gene changes carry the same risk.
Risks differ widely between genes, so advice differs too.
Questions we are asked
Common questions about surgery choice with a BRCA mutation
Is lumpectomy safe if I carry BRCA1 or BRCA2?
For many carriers, lumpectomy with radiotherapy treats the current cancer effectively, and survival is generally similar to mastectomy. The main difference is a higher chance of a new cancer in either breast over the years, which is managed with close screening or later surgery.
Should I remove both breasts at once?
Some carriers choose to, because it lowers the chance of a new cancer in the other breast and avoids a later operation. Others prefer to treat the current cancer first and decide later. Your age, gene, the features of your cancer and your recovery all matter in this choice.
Can I wait for my gene result before surgery?
Often yes, if results can come back within a few weeks and your team agrees a short wait is safe. If chemotherapy is given first, there is usually enough time. If surgery cannot wait, you can treat the cancer and decide on further surgery once results arrive.
What about PALB2 or CHEK2?
PALB2 carries a risk that can approach BRCA2 levels, so similar options are often discussed. CHEK2 and ATM are moderate-risk genes, and most carriers are managed with enhanced screening rather than surgery on the other breast, unless family history adds significant risk.
Why is radiotherapy avoided with TP53?
People with harmful TP53 changes may be more likely to develop new cancers in areas exposed to radiation. For this reason, mastectomy is usually preferred so that radiotherapy can be avoided where possible. A specialist team will guide care for this rare situation.
Does surgery on the other breast help me live longer?
For some carriers, particularly younger women with BRCA1 changes, studies suggest a possible survival benefit, but the evidence is not definitive. For older carriers or those whose first cancer carries a high risk of spread, the benefit is likely smaller. Ask your team about your situation.
When should I think about my ovaries?
Removing the ovaries and tubes is usually advised for BRCA carriers once childbearing is complete, at an age that differs between BRCA1 and BRCA2. It lowers ovarian cancer risk and may be combined with breast cancer treatment planning. Discuss timing with a gynaecological oncologist.
What should my relatives do?
Parents, siblings and children may carry the same change. Your genetics team can provide a letter explaining your result so relatives can seek counselling and testing. Adults can then decide whether to be tested and plan screening or prevention.
Meet the Specialists
17+ senior cancer specialists. One panel for your case.
Trained at AIIMS, Tata Memorial, and leading international centres. Combined 150+ years of experience. Every complex case is reviewed by 3+ of them — together.
Medical Oncologist
Dr. C. Raghavendra Reddy
MBBS(Gold Medal), DNB(General Medicine), DM(Medical Oncology)(Gold Medal)
Medical Oncologist
Dr. Bharati Devi Gorantla
MBBS, MD(General Medicine), DM(Medical Oncology)(Adyar,Chennai), ECMO, MRCP SCE(UK)
Medical Oncologist
Dr. Owais Mohammed
MBBS, MD (General Medicine), DrNB (Medical Oncology), ECMO, MRCP SCE (Medical Oncology) (UK)
Medical Oncologist
Medical Oncologist
Surgical Oncologist
Dr. Muralidhar Muddusetty
MBBS (AIIMS), MS (Surgery) (AIIMS), DNB (Surgical Oncology), MRCS (Edinburgh)
Surgical Oncologist
Surgical Oncologist
Surgical Oncologist
Dr. Vinay Mamidala
MBBS, MS(General Surgery), M.Ch(Surgical Oncology), FMAS, FARIS(Ongoing)
Surgical Oncologist
Radiation Oncologist
Radiation Oncologist
Radiation Oncologist
Hematologist
Surgical Oncologist
Dr. Vajja Sandeep Kumar
MBBS, MS (General Surgery), DrNB (Surgical Oncology), FALS Oncology
Surgical Oncologist
Want a specific doctor for your case? Mention them when booking.
Book Free ConsultationBook an appointment with our specialist
Share your name and number — we'll call you back within 30 minutes to schedule your consultation.
Where to find us
Our centres in and around Hyderabad
Addressed by landmark, because that is how this city navigates. Each centre also names the areas it serves, so you can place it without a map. Consultation and day-care Chemotherapy run at every one of them.
Warangal
Vizag
Talk to our team
Speak to a breast cancer specialist
Call the helpline or leave your details, and someone will help you arrange a consultation at the CION centre nearest you. One helpline serves every CION centre.
Call 1800 202 8726
Helpline open 24/7
Sources
- National Cancer Institute — BRCA gene changes: cancer risk and genetic testing
- American Society of Clinical Oncology — Management of hereditary breast cancer guideline
- American Cancer Society — Surgery for breast cancer
This page is general information, not a prescription. Do not change or stop any treatment based on what you read here. If anything is worrying you, contact your own treating team — or call our helpline and we will help you reach the right specialist.